Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?

Joint Bone Spine. 2021 May;88(3):105150. doi: 10.1016/j.jbspin.2021.105150. Epub 2021 Feb 4.

Authors

Ciro Manzo¹, Alberto Castagna², Giovanni Ruotolo³

Affiliations

¹ Azienda Sanitaria Locale Napoli 3 sud, Internal and Geriatric Medicine department. Rheumatologic outpatient clinic, health district no. 59 Sant'Agnello, Naples, Italy. Electronic address: manzoreumatologo@libero.it.
² Azienda Sanitaria Provinciale Catanzaro. Primary care department, Casa della salute Chiaravalle Centrale Chiaravalle, Catanzaro, Italy.
³ Azienda Ospedaliera "Pugliese-Ciaccio", Geriatric Medicine department, Catanzaro, Italy.

No abstract available

Keywords: Interleukin-6; Polymyalgia rheumatica; Relapse of disease; SARS-CoV-2.

Publication types

Letter

MeSH terms

COVID-19*
Giant Cell Arteritis*
Humans
Polymyalgia Rheumatica* / diagnosis
Polymyalgia Rheumatica* / drug therapy
Recurrence
SARS-CoV-2